Changing Role of Pharmacist in Revision of Medical Fee
Atsushi Murase; Manabu Kitakoji; Toru Otori; Sumio Matzno
J Community Pharm Pharm Sci 11 (2) 165 - 172 2019/10
[Refereed] In order to examine the role of the pharmacist in medical care, we analyzed “arrangement of the previous discussions related to the revision of medical service fees for 2014, 2016 and 2018”. Co-occurrence network analysis suggested that “hospital”, “patient” and “reevaluation” formed strongly connected cluster. “Patient” was also connected with other two groups. One group included “pharmacy”, “drug” and “management” and the other included “home”, “visit” and “nursing”. Furthermore, correspondence analysis suggested that 2014 had relations to “hospital” and “home”, 2016 had relations to “hospital”, “care” and “outpatients” and 2018 had relations not only to “doctor” and “drugs” but also “area”, “visit” and “support”. Therefore, the government’s policy to shift the role of the pharmacist from hospitals to home medical care was clarified.